Key result
Persistent donor HLA alloantigens past 26 weeks post-transplant linked to increased risk of coronary disease.
Observational (n=274)
Answers are grounded in this paper and cite their sources.
Demonstrates that monitoring circulating soluble donor HLA antigens and antibodies predicts transplant coronary artery disease in heart recipients, highlighting immune markers of chronic graft injury.
The development of accelerated transplant-related coronary artery disease (T-CAD) is the major obstacle to long-term survival of cardiac allografts. We have investigated the role of various demographic and immunologic parameters as prognostic indicators of T-CAD in a population of 274 heart allograft recipients. Our data demonstrate that patients who experience more than 1 episode of acute rejection per year and/or develop antidonor HLA antibodies are at increased risk of developing T-CAD. Using HLA-A2 as a marker for the release of soluble HLA antigens from the donor, we established that recipients displaying circulating donor alloantigens for more than 26 weeks following transplantation are at increased risk of developing T-CAD (P=0.008). This association suggests that the release of alloantigens from the allograft is indicative of chronic injury and/or that it stimulates chronic rejection via the indirect allorecognition pathway. Our findings indicate that patients at risk of developing T-CAD can be identified by monitoring the release of donor alloantigens and production of antidonor HLA antibodies following transplantation.
No takes yet. Share an insight, caveat, or question.
Reed et al. (1996) conducted an observational in Transplant-associated coronary artery disease (T-CAD) in heart allograft recipients (n=274). Circulating donor soluble HLA alloantigens (>26 weeks) and antidonor HLA antibodies vs. Absence of persistent circulating donor alloantigens or antidonor HLA antibodies was evaluated on Development of transplant-related coronary artery disease (T-CAD) (p=0.008). Circulating donor HLA alloantigens for >26 weeks post-transplantation increased the risk of transplant-related coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: